Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04705818
Title Combining Epigenetic And Immune Therapy to Beat Cancer. (CAIRE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Institut Bergonié
Indications

pancreatic cancer

colorectal cancer

Advanced Solid Tumor

sarcoma

Therapies

Durvalumab + Tazemetostat

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST